Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.

Eitemau Tebyg

• Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.
  gan: Elliot, M, et al.
  Cyhoeddwyd: (2008)
• Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis.
  gan: Elliott, M, et al.
  Cyhoeddwyd: (1994)
• Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis.
  gan: Elliott, M, et al.
  Cyhoeddwyd: (1994)
• Selective immunosuppression of tumour necrosis factor-alpha in rheumatoid arthritis.
  gan: Brennan, F, et al.
  Cyhoeddwyd: (1995)
• Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis.
  gan: Paleolog, E, et al.
  Cyhoeddwyd: (1996)